PBI4 Outcomes with Infliximab and Its Biosimilars in Patients with Rheumatoid Arthritis (RA): Real-World Experience in the US
Abstract
Authors
S.M. Helfgott J. Radtchenko N. Soloman K. Huston J.A. Singh C. Edgerton
S.M. Helfgott J. Radtchenko N. Soloman K. Huston J.A. Singh C. Edgerton
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now